🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Canada
Clinical trial register · Canada

Studies with a Canadian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6540 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:55 UTC
6540
Studies in scope
all four open statuses
3515
Recruiting now
open to new participants
887
Lead sponsors
across recruiting studies
Top sites
Toronto 2809 Montreal 1902 Vancouver 1179 Calgary 1061 Edmonton 1017
Narrow the register
Recruitment status
Phase
Lead sponsor
University Health Network, Toronto349 University of British Columbia197 AstraZeneca190 University of Alberta180 University of Calgary149
Site location
Toronto2809 Montreal1902 Vancouver1179 Calgary1061 Edmonton1017
All 255 locations
Target enrolment
to

Trials in this register

6540 of 6540 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
NCT02249923Pulmonary Vascular Disease, Pulmonary Arterial Hypertension
New York Medical College
Observational
2,500
Edmonton
2014-10
Active, closed
Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound
NCT02343991Brain Tumor
InSightec
Not applicable
10
Toronto
2014-10
Active, closed
Tomosynthesis Mammographic Imaging Screening Trial
NCT02616432Breast Cancer
Sunnybrook Health Sciences Centre
Not applicable
3,065
Vancouver, Ottawa, Toronto
2014-10
Recruiting
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
NCT02678884Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto
Not applicable
20
Toronto
2014-10
Recruiting
International Rare Histiocytic Disorders Registry (IRHDR)
NCT02285582Rare Histiocytic Disorders (RHDs), Erdheim-Chester Disease (ECD), Rosai-Dorfman Disease (RDD), Xanthogranuloma Family (XG)
The Hospital for Sick Children
Observational
400
Toronto, Montreal
2014-10
Active, closed
Disease Status in Primary Sclerosing Cholangitis by Elastography
NCT02446665Primary Sclerosing Cholangitis, Elastography, Hepatic Fibrosis, Magnetic Resonance Imaging
University Health Network, Toronto
Not applicable
82
Toronto
2014-10
Recruiting
Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses
NCT04050423Breast Cancer
Sunnybrook Health Sciences Centre
Observational
1,200
Toronto
2014-09-23
Active, closed
Prostate Hypoxia - TIC
NCT02095249Prostate Cancer
DrugPimonidazole
University Health Network, Toronto
Not applicable
39
Toronto
2014-09
Active, closed
ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease
NCT02347254Parkinson's Disease
InSightec
Not applicable
6
Toronto
2014-09
Active, closed
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
NCT02259621Non-Small Cell Lung Cancer
DrugsParaplatin·Taxol·Ipilimumab·Nivolumab
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2
39
Montreal
2014-09
Active, closed
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
NCT02130362Crohn's Disease
AbbVie
Observational
1,446
Edmonton, Winnipeg, Halifax, London, Toronto
2014-08-28
Active, closed
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
NCT02176967Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Neuroblastoma
DrugsDoxorubicin Hydrochloride·Adriamycin·Etoposide·Cyclophosphamide
Children's Oncology Group
Phase 3
621
Calgary, Edmonton, Vancouver, Winnipeg, St. John's, Halifax, Hamilton, Kingston
2014-08-08
Active, closed
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
NCT02143466Advanced Non Small Cell Lung Cancer
DrugsSavolitinib·Selumetinib·Osimertinib·Durvalumab
AstraZeneca
Phase 1
344
Calgary, Edmonton
2014-08-05
Recruiting
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
NCT04134780Breast Cancer
Sunnybrook Health Sciences Centre
Observational
150
Toronto
2014-08
Active, closed
Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer
NCT02560181Prostate Cancer Recurrent
Sunnybrook Health Sciences Centre
Not applicable
30
Toronto
2014-08
Recruiting
Cardiovascular Imaging Registry of Canada
NCT04367220Cardiovascular Diseases
University of Calgary
Observational
45,000
Calgary
2014-08
Active, closed
Attune With TruMatch TM Personalized Solutions Instruments
NCT02177227Obesity, Osteoarthritis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicable
194
London
2014-08
Active, closed
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
NCT02107703Breast Neoplasms
DrugsAbemaciclib·Fulvestrant
Eli Lilly and Company
Phase 3
669
Calgary, London, Toronto
2014-07-22
Active, closed
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02101775Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor
DrugsAdavosertib·Gemcitabine
National Cancer Institute (NCI)
Phase 2
124
Kelowna, Vancouver, London, Ottawa, Toronto, Montreal
2014-07-21
Active, closed
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT02123758Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer
DrugsZytiga·Apalutamide·Abiraterone acetate·Prednisone
Aragon Pharmaceuticals, Inc.
Phase 1
57
Vancouver, Montreal
2014-07-09
Active, closed
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NCT02135042EBV Infection, Stage II Nasopharyngeal Carcinoma AJCC v7, Stage III Nasopharyngeal Carcinoma AJCC v7, Stage IVA Nasopharyngeal Carcinoma AJCC v7
DrugsFluorouracil·Gemcitabine·Paclitaxel·Cisplatin
NRG Oncology
Phase 2/3
924
Calgary, Edmonton, London, Toronto, Montreal
2014-07-01
Recruiting
Personalized Oncogenomics (POG) Program of British Columbia
NCT02155621Metastatic Cancers, Advanced Cancers, Cancers That Cannot be Treated With Curative Intent
British Columbia Cancer Agency
Not applicable
5,000
Vancouver
2014-07
Recruiting
Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis
NCT07764497Colorectal Adenocarcinoma Metastatic in the Liver, Liver Metastasis Colon Cancer, Liver Metastases From Colorectal Cancer, Liver Metastases of Colorectal Cancer
DrugFloxuridine
Sunnybrook Health Sciences Centre
Phase 2
200
Toronto
2014-07
Active, closed
Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections
NCT02143245Total Shoulder Arthroplasty
Ottawa Hospital Research Institute
Not applicable
118
London, Ottawa, Toronto, Montreal
2014-06
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Montreal, Toronto
2014-06
Active, closed
UW WELL-FIT Exercise Program for Cancer Patients
NCT02734394Cancer
University of Waterloo
Not applicable
200
Waterloo
2014-06
Recruiting
90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors
NCT02081768Cystic Tumors of the Sellar/Parasellar Region
David Clarke
Phase 3
40
Halifax
2014-06
Active, closed
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
NCT02003222Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
DrugsLeucovorin Calcium·Blinatumomab·Daunorubicin·Cytarabine
National Cancer Institute (NCI)
Phase 3
488
Calgary, Vancouver, Halifax, Kingston, Montreal, Regina
2014-05-19
Active, closed
PERIGON Pivotal Trial
NCT02088554Aortic Stenosis
Medtronic Cardiac Surgery
Not applicable
1,312
London, Ottawa, Montreal, Québec, Toronto
2014-05-12
Recruiting
Treatment of Brain AVMs (TOBAS) Study
NCT02098252Unruptured Brain Arteriovenous Malformation, Ruptured Brain Arteriovenous Malformation, Arteriovenous Malformations, AVM
Centre hospitalier de l'Université de Montréal (CHUM)
Not applicable
1,000
Edmonton, Montreal
2014-05
Active, closed
Multidisciplinary Team IntervenTion in CArdio-ONcology (TITAN Study)
NCT01621659Breast Cancer
University of Alberta
Phase 2
80
Edmonton
2014-05
Recruiting
Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis
NCT02434003Scoliosis
St. Justine's Hospital
Observational
1,200
Montreal
2014-05
Active, closed
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
NCT02032823Breast Cancer
DrugOlaparib
AstraZeneca
Phase 3
1,837
Edmonton, Vancouver, Winnipeg, Hamilton, Toronto, Greenfield Park, Montreal, Québec
2014-04-22
Active, closed
Cervical Spondylotic Myelopathy Surgical Trial
NCT02076113Cervical Spondylosis With Myelopathy
Lahey Clinic
Not applicable
269
Toronto
2014-04-01
Active, closed
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
NCT01915615Hypertrophic Cardiomyopathy
University of Virginia
Observational
2,750
Calgary, Toronto, Montreal, Québec
2014-04
Recruiting
Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
NCT05786742Prostate Cancer, Radiotherapy Side Effect, Hypofractionation, Brachytherapy
CHU de Quebec-Universite Laval
Not applicable
205
Québec
2014-04
Recruiting
Skills for Wellness
NCT01980147Schizophrenia, Bipolar Disorder, Major Depression
Nova Scotia Health Authority
Not applicable
360
Halifax
2014-03-22
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
NCT01790152Hodgkin Lymphoma in Remission, Leukemia in Remission, Lymphoblastic Lymphoma, Osteosarcoma
Children's Oncology Group
Observational
420
Calgary, Hamilton, Ottawa, Toronto, Montreal, Québec
2014-03-05
Recruiting
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
NCT02071134Parkinson's Disease
Boston Scientific Corporation
Observational
1,500
Halifax, Québec
2014-03-04
Active, closed
Prophylactic Antibiotics or Placebo After Hypospadias Repair
NCT02096159Hypospadias
DrugTrimethoprim-sulfamethoxazole
Ann & Robert H Lurie Children's Hospital of Chicago
Not applicable
93
Toronto
2014-03
Active, closed
Zimmer Trabecular Metal Total Ankle PMCF
NCT02038140Degenerative Arthritis, Rheumatoid Arthritis, Post Traumatic Arthritis
Zimmer Biomet
Not applicable
120
Vancouver
2014-03
Active, closed
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
NCT02446405Prostatic Neoplasms
DrugsLhrha·Enzalutamide
University of Sydney
Phase 3
1,125
Calgary, Edmonton, Surrey, Vancouver, Winnipeg, Fredericton, Saint John, Halifax
2014-03
Active, closed
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
NCT01901094Stage II Breast Cancer, Stage IIIA Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3
2,012
Edmonton, Winnipeg, Saint John, Barrie, London, Ottawa, Toronto, Montreal
2014-02-24
Active, closed
Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation
NCT02024854Premature Birth
Norwegian University of Science and Technology
Not applicable
108
Halifax
2014-02-01
Active, closed
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
NCT01886872Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
DrugsIbrutinib·Bendamustine·Rituximab
National Cancer Institute (NCI)
Phase 3
547
Calgary, Moncton, Halifax, Greater Sudbury, Hamilton, Kingston, London, Newmarket
2014-01-15
Active, closed
Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy
NCT01936883Prostate Cancer
British Columbia Cancer Agency
Not applicable
195
Kelowna
2014-01
Recruiting
DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
NCT02288676Ovarian Neoplasms, Endometrial Neoplasms, Endometrial Cancer, Ovarian Cancer
McGill University
Observational
1,200
Montreal
2014-01
Recruiting
Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The "MARE" Study
NCT02153307Aortic Valve Disease, Conduction Disturbances
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Not applicable
80
Québec
2014-01
Active, closed
Prostate Screening Study Using MRI in BRCA Carriers
NCT01990521Prostate Cancer
Toronto Sunnybrook Regional Cancer Centre
Not applicable
60
Toronto
2014-01
Active, closed
NOVOCART®3D for Treatment of Articular Cartilage of the Knee
NCT01957722Articular Cartilage of the Femoral Condyle Between 2-6cm2
DrugNOVOCART 3D
Aesculap Biologics, LLC
Phase 3
233
Edmonton, Surrey, Halifax, Hamilton, London
2013-12
Recruiting
Genomic Investigation of Unusual Responders
NCT03740503Cancer, Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer
University Health Network, Toronto
Observational
100
Toronto
2013-11-01
Active, closed
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
NCT01983241Pulmonary Emphysema in Alpha-1 PI Deficiency
DrugAlpha-1 MP
Grifols Therapeutics LLC
Phase 3
345
St. John's, Halifax, Toronto
2013-11
Recruiting
Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
NCT02009345Familial Hypercholesterolemia, Lipid Disorder
McGill University Health Centre/Research Institute of the McGill University Health Centre
Observational
6,000
Montreal
2013-11
Active, closed
International Bicuspid Aortic Valve Consortium (BAVCon)
NCT01980797Bicuspid Aortic Valve Disease, Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve
Boston University
Observational
6,464
Québec
2013-11
Active, closed
Comprehensive Nano - Post Market Clinical Follow-Up Study
NCT03423953Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Revision
Zimmer Biomet
Observational
194
Kingston
2013-10-30
Active, closed
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
NCT01946204Prostatic Neoplasms
DrugApalutamide
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Calgary, Edmonton, Abbotsford British Columbia, Kelowna, Vancouver, Victoria, Moncton, Saint John
2013-10-14
Active, closed
Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI
NCT02306538Breast Neoplasms
University Health Network, Toronto
Observational
180
Toronto
2013-10
Active, closed
Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC
NCT01933932Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
DrugsPegfilgrastim·Selumetinib·Docetaxel
AstraZeneca
Phase 3
510
Edmonton, Kelowna, Surrey, Halifax, Oshawa, Toronto, Montreal, Québec
2013-09-25
Active, closed
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT01955499Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma, Recurrent Lymphoplasmacytic Lymphoma, Recurrent Mantle Cell Lymphoma
DrugsIbrutinib·Lenalidomide
National Cancer Institute (NCI)
Phase 1
39
Toronto
2013-09-24
Active, closed
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
NCT01841736Foregut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor, Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Neuroendocrine Tumor
National Cancer Institute (NCI)
Phase 2
171
Calgary, Vancouver, Moncton, Halifax, Hamilton, Kitchener, Ottawa, Toronto
2013-09-20
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
700
Montreal
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Hamilton, London, Toronto, Montreal, Québec, Sherbrooke
2013-09-03
Recruiting
The Next Generation Longitudinal Birth Cohort Diabetes Study
NCT04621396Type 2 Diabetes, Gestational Diabetes Mellitus
University of Manitoba
Observational
600
Winnipeg
2013-09
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Hamilton, London, Toronto, Montreal, Québec
2013-08-26
Active, closed
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
NCT01872975Stage IB Breast Cancer, Stage II Breast Cancer
NSABP Foundation Inc
Not applicable
1,636
Calgary, Edmonton, Winnipeg, Saint John, Toronto, Montreal, Québec, Sherbrooke
2013-08
Active, closed
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
NCT01892722Multiple Sclerosis
DrugsRebif·Fingolimod
Novartis Pharmaceuticals
Phase 3
240
Calgary, Ottawa
2013-07-26
Active, closed
The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial
NCT00936819Anterior Wall Myocardial Infarction
Ottawa Hospital Research Institute
Phase 2
47
Ottawa, Toronto, Montreal
2013-07-19
Active, closed
A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer
NCT01791829Breast Cancer
Ontario Clinical Oncology Group (OCOG)
Observational
500
Calgary, Abbotsford British Columbia, Prince George, Vancouver, Victoria, Winnipeg, Barrie, Greater Sudbury
2013-07
Active, closed
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
NCT01878617Medulloblastoma
DrugsVismodegib·Vincristine·Pemetrexed·Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2
660
Calgary, Toronto, Montreal
2013-06-23
Active, closed
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)
NCT03383016Epidemiology, Prostate Cancer
CHU de Quebec-Universite Laval
Observational
2,053
Montreal, Québec, Sherbrooke
2013-06-20
Active, closed
Employment and Arthritis: Making it Work
NCT01852851Rheumatoid Arthritis, Ankylosing Spondylitis, Lupus Erythematosus, Systemic, Psoriatic Arthritis
University of British Columbia
Not applicable
528
Richmond
2013-06
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Edmonton, Halifax, London, Québec
2013-05-30
Active, closed
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
NCT01843374Unresectable Pleural or Peritoneal Malignant Mesothelioma
DrugTremelimumab
MedImmune LLC
Phase 2
571
Toronto, Sainte-Foy
2013-05-17
Active, closed
Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk
NCT02037321Diabetes, Prediabetes, Metabolic Syndrome, Dysglycemia
John Sievenpiper
Observational
1
Toronto
2013-05
Active, closed
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
NCT01848561Ulcerative Colitis (UC)
AbbVie
Observational
8,250
Edmonton, New Westminster, Surrey, Vancouver, Victoria, Fredericton, Halifax, Brampton
2013-04-29
Active, closed
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
NCT01849263Grade 3a Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma
DrugIbrutinib
National Cancer Institute (NCI)
Phase 2
41
Hamilton, Kingston, Toronto
2013-04-02
Recruiting
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
NCT01949129Acute Lymphoblastic Leukaemia
DrugsGrafalon·Treosulfan·Thiotepa·Busulfan
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Calgary, Montral, Montreal, Toronto, Vancouver, Winnipeg
2013-04
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
London, Toronto, Montreal, Québec
2013-03-18
Active, closed
HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
NCT01796457Hepatitis B
University of Pennsylvania
Observational
40
Toronto
2013-03
Active, closed
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
NCT01711554Recurrent Neuroblastoma, Refractory Neuroblastoma
DrugsDinutuximab·Isotretinoin·Lenalidomide
National Cancer Institute (NCI)
Phase 1
27
Toronto
2013-02-04
Active, closed
Survivorship of Attune Primary Total Knee Prosthesis
NCT01754363Noninflammatory Degenerative Joint Disease
DePuy International
Not applicable
1,542
London
2013-02-01
Recruiting
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)
NCT01786590Lung Cancer
University Health Network, Toronto
Not applicable
150
Toronto
2013-02
Active, closed
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668Juvenile Idiopathic Arthritis
Bristol-Myers Squibb
Observational
800
Calgary, Montreal
2013-01-30
Recruiting
Hairy Cell Leukemia Patient Data Registry
NCT02560883Leukemia, Other
Ohio State University Comprehensive Cancer Center
Observational
5,000
Vancouver, Winnipeg
2013-01-02
Active, closed
PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty
NCT03372278Rheumatoid Arthritis With Adequate Bone Quality, Inflammatory Arthritis, Osteoarthritis, Hip, Avascular Necrosis
Zimmer Biomet
Observational
250
Montreal
2013-01
Recruiting
Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency
NCT01756365Limbal Stem Cell Deficiency
CHU de Quebec-Universite Laval
Not applicable
54
Toronto, Montreal, Québec
2012-12
Active, closed
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
NCT01760005Alzheimers Disease, Dementia, Alzheimers Disease, Familial
DrugsE2814·Lecanemab
Washington University School of Medicine
Phase 2/3
490
Vancouver, Toronto, Verdun, Québec
2012-12
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
NCT01719055Pain
Boston Scientific Corporation
Observational
4,800
London, Québec, Regina
2012-11-19
Recruiting
The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars
NCT01619917Burn Scar
University of Manitoba
Not applicable
6
Winnipeg
2012-11-01
Recruiting
The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
NCT01488240Burn Scar
University of Manitoba
Not applicable
6
Winnipeg
2012-11-01
Recruiting
Clinical Outcomes in Pediatric Obsessive-Compulsive Disorder
NCT01635569Obsessive-compulsive Disorder
University of British Columbia
Not applicable
180
Vancouver
2012-10-01
Recruiting
Gut Microbiota in Chronic GI Diseases
NCT06532110Microbiota
McMaster University
Observational
260
Hamilton
2012-10-01
Active, closed
Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
NCT01599559Primary Mediastinal B-cell Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
Not applicable
540
Toronto
2012-10
Active, closed
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
NCT01415752Lymphoma, Mantle Cell Lymphoma
DrugsBendamustine·Bortezomib·Lenalidomide·Rituximab
Eastern Cooperative Oncology Group
Phase 2
373
Moncton, Regina
2012-08-09
Active, closed
Prostate Advances in Comparative Evidence
NCT01584258Prostate Cancer
Royal Marsden NHS Foundation Trust
Phase 3
2,205
Greater Sudbury, Hamilton, London, Niagara, Oshawa, Ottawa, Toronto, Montreal
2012-08-07
Active, closed
Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain
NCT04798573Chronic Pain, Surgery
University Health Network, Toronto
Observational
10,000
Toronto
2012-08-03
Recruiting
Cardiac Sarcoidosis Multi-Center Prospective Cohort
NCT01477359Cardiac Sarcoidosis
Ottawa Heart Institute Research Corporation
Observational
1,500
Calgary, Edmonton, Vancouver, Halifax, Hamilton, London, Newmarket, Ottawa
2012-08
By invitation
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
NCT02040714Legg Calve Perthes Disease
Texas Scottish Rite Hospital for Children
Observational
1,500
Calgary, Vancouver
2012-08
Recruiting
Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors
NCT01736748Obese
St. Justine's Hospital
Not applicable
100
Montreal
2012-08
Active, closed
Evaluation of IVA (SE Femur Scans) to Identify Incomplete AFFs
NCT01747304Atypical Femur Fracture
University Health Network, Toronto
Observational
285
Toronto
2012-07
Rows per page Showing 6301–6400 of 6540
Previous 62 63 64 65 66 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-canada?page=64

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,540 studies in total at the last sync on 26 Sep 2026, 19:55 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Canada?

3,515 of the 6,540 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:55 UTC sync. A further 629 have not yet opened recruitment, 2,212 are active but closed to new participants, and 184 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (136) Prostate Cancer (110) Cancer (75) Obesity (64) Multiple Myeloma (63) Stroke (57) Heart Failure (56) Ulcerative Colitis (43) Non-small Cell Lung Cancer (39) Type 2 Diabetes (39) Non-Small Cell Lung Cancer (38) Atrial Fibrillation (38) Healthy (36) Anxiety (35) Asthma (35)
→

Browse trials by site location

Toronto (2809) Montreal (1902) Vancouver (1179) Calgary (1061) Edmonton (1017) Ottawa (872) London (871) Hamilton (809) Québec (678) Halifax (533) Winnipeg (455) Sherbrooke (265) Kingston (256) Kelowna (172) Brampton (147)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.